Odyssey Health, Inc., a medical company, focuses on the development and acquisition of medical related products. The company develops CardioMap, a heart monitoring and screening device; Save A Life choking rescue devices; and neurosteroid drug compounds to treat rare brain disorders. Its product candidates include ONP-001 and ONP-002 for the treatment of mild brain trauma or concussion. The company was formerly known as Odyssey Group International, Inc. Odyssey Health, Inc. was incorporated in 2014 and is based in Las Vegas, Nevada.